RESUMO
Type 1 allergic disease is a global challenge, hence the search for alternative therapies. Mushrooms have several medicinal and health benefits. However, scant data exist on the anti-allergic properties of polysaccharides from fruiting bodies (FB) and mycelia of mushrooms. We used an in vitro co-culture system comprising Caco-2 cells (intestinal epithelial colorectal carcinoma cell line) and RBL-2H3 cells (cell line from rat basophilic leukemia cells). Reduction in degranulation of mast cells indicated anti-allergy properties. The inhibitory effect of crude polysaccharides from different mushroom FB and mycelia on ß-hexosaminidase release from RBL-2H3 cells was measured. Results showed that crude polysaccharides from the FB of Inonotus obliquus exhibited a significant inhibitory effect on ß-hexosaminidase release and lowered it by 16%. Polysaccharides from the FB of Lentinus squarrosulus, and Pleurotus ostreatus did not exhibit a significant reduction in ß-hexosaminidase. However, crude polysaccharides from their mycelia had a significant inhibitory effect, resulting in up to a 23% reduction in ß-hexosaminidase activity. Among fungi showing degranulation properties, crude polysaccharides from their mycelia showed more potent action against degranulation than their corresponding FB. Polysaccharides extracted from FB and or mycelia, of selected mushrooms, possess anti-allergic properties that could be harnessed for use in alternative allergy therapies.
Assuntos
Agaricales , Antialérgicos , Hipersensibilidade , Animais , Ratos , Humanos , Antialérgicos/farmacologia , Células CACO-2 , beta-N-Acetil-HexosaminidasesRESUMO
Currently, aging is an important social problem globally [...].
Assuntos
Avaliação Nutricional , Insuficiência Renal Crônica , Humanos , Suplementos Nutricionais , Nutrientes , Envelhecimento , Estado NutricionalRESUMO
4,8-Sphingadienines (SD), metabolites of glucosylceramides (GlcCer), are sometimes determined as key mediators of the biological activity of dietary GlcCer, and cis/trans geometries of 4,8-SD have been reported to affect its activity. Since regulating excessive activation of mast cells seems an important way to ameliorate allergic diseases, this study was focused on cis/trans stereoisomeric-dependent inhibitory effects of 4,8-SD on mast cell activation. Degranulation of RBL-2H3 was inhibited by treatment of 4-cis-8-trans- and 4-cis-8-cis-SD, and their intradermal administrations ameliorated ear edema in passive cutaneous anaphylaxis reaction, but 4-trans-8-trans- and 4-trans-8-cis-SD did not. Although the activation of mast cells depends on the bound IgE contents, those stereoisomers did not affect IgE contents on RBL-2H3 cells after the sensitization of anti-TNP IgE. These results indicated that 4-cis-8-trans- and 4-cis-8-cis-SD directly inhibit the activation of mast cells. In conclusion, it was assumed that 4,8-SD stereoisomers with cis double bond at C4-position shows anti-allergic activity by inhibiting downstream pathway after activation by the binding of IgE to mast cells.
Assuntos
Antialérgicos/farmacologia , Degranulação Celular/efeitos dos fármacos , Etanolaminas/farmacologia , Mastócitos/efeitos dos fármacos , Anafilaxia Cutânea Passiva/efeitos dos fármacos , Animais , Antialérgicos/química , Células CACO-2 , Linhagem Celular Tumoral , Orelha/patologia , Edema/prevenção & controle , Etanolaminas/química , Etanolaminas/metabolismo , Feminino , Glucosilceramidas/química , Glucosilceramidas/metabolismo , Glucosilceramidas/farmacologia , Humanos , Mastócitos/fisiologia , Camundongos Endogâmicos BALB C , Estrutura Molecular , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Ratos , EstereoisomerismoRESUMO
The incidence of inflammatory bowel disease (IBD) has continued to increase worldwide, and a caspase-in-dependent, proinflammatory form of programmed cell death termed necroptosis has been observed to actively play an important role in its pathogenesis. Recent studies have indicated that polysaccharides from edible mushrooms suppress colitis. However, there is a lack of information on the effect of mushroom polysaccharides on colitis-associated necroptosis. In this study, the anti-inflammatory activity of polysaccharides from Lentinus edodes and their impact on colitis-associated necroptosis was investigated using both in vivo and in vitro models. Polysaccharides extracted from L. edodes were administered to mice with dextran sodium sulphate-induced colitis prior to and during colitis induction. The Caco-2 cell model of necroptosis was used to investigate the antinecroptotic activity of the polysaccharide sample in an in vitro system. We found that polysaccharides from L. edodes suppressed colitis in mice in a dose-dependent manner and inhibited necroptotic cell death in Caco-2 cells. Interestingly, the polysaccharide extract exerted a remarkable inhibitory effect on the receptor-interacting protein kinase RIPK1-RIPK3-MLKL (mixed lineage kinase domain-like pseudokinase) necroptosis signaling cascade, which resulted in a decreased level of phosphorylated MLKL in the colon of mice with colitis. Notably, the anti-inflammatory and antinecroptotic activities of the polysaccharide sample were found to be dependent on the carbohydrate-rich fraction of the polysaccharides. These results suggested that the inhibitory effect of the polysaccharides from L. edodes on necroptotic cell death in the colon may be partly responsible for its anti-inflammatory activity against ulcerative colitis. Therefore, this study provides evidence for the antinecroptotic and anti-inflammatory activity of L. edodes polysaccharide extract to support its use as an alternative source of therapeutic agent against ulcerative colitis.
Assuntos
Colite , Cogumelos Shiitake , Animais , Células CACO-2 , Morte Celular , Colite/induzido quimicamente , Colite/tratamento farmacológico , Humanos , Camundongos , Polissacarídeos/farmacologiaRESUMO
Selenium is essential for human health; its deficiency leads to cardiac dysfunction. We herein report a 79-year-old man on peritoneal dialysis who presented with refractory hypotension caused by selenium deficiency. He was admitted to our hospital with bacterial pneumonia and hypotension and abnormal electrocardiogram (ECG) findings. Despite improvement of pneumonia, his hypotension continued, and intravenous noradrenalin could not be discontinued. His serum selenium level was extremely low, and he was started on intravenous selenium. His hypotension and ECG findings gradually improved, and noradrenalin was discontinued. Physicians should consider selenium deficiency when patients on peritoneal dialysis show refractory hypotension.
Assuntos
Hipotensão , Desnutrição , Diálise Peritoneal , Selênio , Idoso , Humanos , Hipotensão/etiologia , Masculino , Diálise Peritoneal/efeitos adversosRESUMO
A previous study revealed that fucoidan inhibited mast cell degranulation through the upregulation of galectin-9 in blood. The purpose of this study is to elucidate its mechanism using ovalbumin (OVA) induced anaphylaxis model mice (BALB/c, Female, 5-week-old) and mast cell line (RBL-2H3 cells). Oral administration of fucoidan after sensitization with OVA/Al(OH)3 inhibited reduction of rectal temperature induced by activation of mast cells. Fucoidan increased galectin-9 mRNA expression only in colonic epithelial cells. These results suggested that fucoidan could suppress the allergic symptoms in sensitized mice by inducing galectin-9 production from colonic epithelial cells. In addition, to check the influence of galectin 9 on the degranulation of mast cells, RBL-2H3 cell lines were treated directly with recombinant galectin-9. As expected, galectin-9 inhibited degranulation of RBL-2H3 cells pre-bound with IgE. Moreover, the residual amounts of IgE on RBL-2H3 cells were decreased by an addition of galectin-9. It was demonstrated that galectin-9 could remove IgE even if IgE was already bound to mast cells and suppress the mast cells degranulation induced by antigen. This study shows that fucoidan might become an effective therapeutic agent for patients already developed type I allergic diseases.
Assuntos
Galectinas/metabolismo , Mastócitos/metabolismo , Polissacarídeos/farmacologia , Administração Oral , Alérgenos/imunologia , Alérgenos/metabolismo , Anafilaxia/imunologia , Animais , Antialérgicos/metabolismo , Antialérgicos/farmacologia , Secreções Corporais/efeitos dos fármacos , Secreções Corporais/imunologia , Linhagem Celular , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Feminino , Galectinas/farmacologia , Galectinas/fisiologia , Humanos , Mastócitos/efeitos dos fármacos , Mastócitos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Ovalbumina/farmacologia , Extratos Vegetais/farmacologia , Polissacarídeos/administração & dosagem , RatosRESUMO
Agaricus brasiliensis has been demonstrated to have potent antitumor activity. The activity is postulated to act through mediation of the host immune system. We have reported that A. brasiliensis extract (ABE) inhibited compound 48/80 induced a systemic anaphylaxis-like reaction, ear swelling response, and passive cutaneous anaphylaxis-like reaction in mice. There is some recent information available on the mechanism of antiallergic effects resulting from oral administration of ABE. However, information regarding how ABE may activate macrophages through intestinal epithelial cells is still limited. To clarify the mechanism of macrophages activation by ABE, a gut in vitro model constructed of Caco-2 and RAW264.7 cells was applied. Treatment of ABE to the apical compartment resulted in significant increases in tumor necrosis factor (TNF)-α production in the basolateral compartment. Moreover, addition of catalase to the basolateral compartment before ABE treatment suppressed TNF-α production completely, but the addition of superoxide dismutase did not suppress this at all. These data suggest that ABE could potentiate hydrogen peroxide emissions from Caco-2 cells into the basolateral side and activate macrophages, which is important in the immune system.
Assuntos
Agaricus , Ativação de Macrófagos/fisiologia , Macrófagos/efeitos dos fármacos , Animais , Células CACO-2 , Linhagem Celular Tumoral , Humanos , Macrófagos/fisiologia , Camundongos , Espécies Reativas de Oxigênio , Fator de Necrose Tumoral alfaRESUMO
Partial acid hydrolysis of the tetrasaccharide (lycotetraose) side chain of the tomato glycoalkaloid α-tomatine resulted in the formation of four products with three, two, one, and zero carbohydrate side chains, which were separated by high-performance liquid chromatography (HPLC) and identified by thin-layer chromatography (TLC) and liquid chromatography ion-trap time-of-flight mass spectrometry (LCMS-IT-TOF). The inhibitory activities in terms of IC(50) values (concentration that inhibits 50% of the cells under the test conditions) of the parent compound and the hydrolysates, isolated by preparative HPLC, against normal human liver and lung cells and human breast, gastric, and prostate cancer cells indicate that (a) the removal of sugars significantly reduced the concentration-dependent cell-inhibiting effects of the test compounds, (b) PC3 prostate cancer cells were about 10 times more susceptible to inhibition by α-tomatine than the breast and gastric cancer cells or the normal cells, (c) the activity of α-tomatine against the prostate cancer cells was 200 times greater than that of the aglycone tomatidine, and (d) the activity increased as the number of sugars on the aglycone increased, but this was only statistically significant at p < 0.05 for the normal lung Hel299 cell line. The effect of the alkaloids on tumor necrosis factor α (TNF-α) was measured in RAW264.7 macrophage cells. There was a statistically significant negative correlation between the dosage of γ- and α-tomatine and the level of TNF-α. α-Tomatine was the most effective compound at reducing TNF-α. The dietary significance of the results and future research needs are discussed.
Assuntos
Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/farmacologia , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Tomatina/química , Tomatina/farmacologia , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/fisiopatologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Feminino , Humanos , Solanum lycopersicum/química , Masculino , Estrutura Molecular , Próstata , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/fisiopatologia , Neoplasias Gástricas/tratamento farmacológico , Neoplasias Gástricas/fisiopatologia , Tomatina/análogos & derivadosRESUMO
Dietary fucoxanthin has been reported to exert several physiological functions, and fucoxanthinol is considered to be the primary active metabolite of fucoxanthin. However, there is no information about the pharmacokinetics of fucoxanthinol in human subjects. In the present study, eighteen human volunteers were orally administered kombu extract containing 31 mg fucoxanthin, and their peripheral blood was collected 5 min before and 0·5, 1, 2, 4, 8 and 24 h after the treatment. Plasma fucoxanthinol concentrations were measured by HPLC, and the pharmacokinetics of fucoxanthinol were as follows: maximum concentration, 44·2 nmol/l; time at maximum concentration, 4 h; terminal half-time, 7·0 h; area under the curve (AUC) for 1-24 h, 578·7 nmol/l × h; AUC(∞), 663·7 nmol/l × h. In addition to fucoxanthinol, we also attempted to detect amarouciaxanthin A, a hepatic metabolite of fucoxanthinol, using HPLC, but it was not present in the volunteers' plasma. On the other hand, a peak that was suspected to represent the cis-isomer of fucoxanthinol was found in the HPLC chromatogram. By comparing the present results with those of a previous study using mice, we found that the bioavailability and metabolism of fucoxanthinol differ between human subjects and mice.
Assuntos
Suplementos Nutricionais , Laminaria/química , Xantofilas/farmacocinética , beta Caroteno/análogos & derivados , Adulto , Disponibilidade Biológica , Biotransformação , Cromatografia Líquida de Alta Pressão , Suplementos Nutricionais/análise , Feminino , Meia-Vida , Humanos , Masculino , Pessoa de Meia-Idade , Espectrofotometria , Xantofilas/análise , Xantofilas/sangue , Adulto Jovem , beta Caroteno/sangueRESUMO
To clarify the mechanism of the antiallergic activity of Agaricus blazei Murill extract (ABME), the present paper used an in vivo allergy model and an in vitro intestinal gut model. During OVA sensitization, the serum IgE levels decreased significantly in ABME group. Interleukin (IL)-4 and -5 produced from OVA-restimulated splenocytes was significantly decreased, and anti-CD3ε/CD28 antibody treatment also reduced IL-10, -4, and -5 production and increased IFN-γ production in ABME group. These results suggest that oral administration of ABME improves Th1/Th2 balance. Moreover, a coculture system constructed of Caco-2 cells and splenocytes from OT-II mice or RAW 264.7 cells indicated that the significant increases in IFN-γ production by ABME treatment. Therefore, it was concluded that the antiallergic activity of ABME was due to the activation of macrophages by epithelial cells and the promotion of the differentiation of naïve T cells into Th1 cells in the immune.
RESUMO
In potato (Solanum tuberosum L.) suspension cells, the expression of the gene encoding alternative oxidase (AOX) and H2O2 accumulation were induced by treatment with beta-glucan elicitor. The inhibition of catalase activity enhanced both AOX mRNA expression and the production of H2O2, whereas the ascorbate peroxidase inhibitor did not have any effect on these responses. Simultaneous inhibition of catalase and AOX activities in elicited cells dramatically increased H2O2 accumulation, leading to the disruption of mitochondrial membrane potential (deltapsi(m)) and programmed cell death (PCD). The results demonstrate, for the first time, that not only AOX but also catalase plays a central role in the suppression of mitochondrial deltapsi(m) breakdown and PCD induced by beta-glucan elicitor.